Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3,100 new brands collectively earned Rs 1,097 crore, with significant ...

1 Day KTOS -4.90% DJIA -0.37% S&P 500 -0.01% Industrial Goods -0.73% ...

today announced the successful performance of a recent series of flight tests of the United States Marine Corps’ XQ-58A Valkyrie, manufactured by Kratos. These flights and exercises were ...

1 Day KTOS -5.45% DJIA 0.28% S&P 500 0.46% Industrial Goods -1.15% ...

The hybrid design of CATS Warrior combines elements reminiscent of the MQ-28 Ghost Bat and the XQ-58 Valkyrie, with a single serpentine air intake atop its fuselage leading to twin engines. This ...

LCAAT paved the way for the Low Cost Attritable Strike Demonstrator (LCASD) project, through which the Air Force acquired the XQ-58 Valkyrie drones from Kratos. The XQ-58s are now regarded by the USAF ...

What makes the XQ-58 Valkyrie so unique? This video breaks down its advanced technology, AI-driven combat strategies, and its potential role in future warfare. Exoplanet with iron rain has violent ...

The United States Marine Corps completed the second test flight of an unmanned aircraft called the Kratos XQ-58 Valkyrie, piloted by AI, in February last year. This development marked a ...

In a report released today, Michael Ciarmoli from Truist Financial maintained a Buy rating on Kratos Defense (KTOS – Research Report). The company’s shares closed yesterday at $34.38.